- Home
- BMR vs ARMP Comparison
BMR vs ARMP Comparison
Compare BMR & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- ARMP
- Stock Information
- Founded
- BMR 2009
- ARMP N/A
- Country
- BMR Israel
- ARMP United States
- Employees
- BMR N/A
- ARMP N/A
- Industry
- BMR Computer Software: Prepackaged Software
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BMR Technology
- ARMP Health Care
- Exchange
- BMR Nasdaq
- ARMP Nasdaq
- Market Cap
- BMR 59.3M
- ARMP 52.1M
- IPO Year
- BMR 2023
- ARMP N/A
- Fundamental
- Price
- BMR $2.93
- ARMP $1.96
- Analyst Decision
- BMR
- ARMP Strong Buy
- Analyst Count
- BMR 0
- ARMP 1
- Target Price
- BMR N/A
- ARMP $9.00
- AVG Volume (30 Days)
- BMR 76.0K
- ARMP 624.1K
- Earning Date
- BMR 06-10-2025
- ARMP 05-14-2025
- Dividend Yield
- BMR N/A
- ARMP N/A
- EPS Growth
- BMR N/A
- ARMP N/A
- EPS
- BMR N/A
- ARMP N/A
- Revenue
- BMR $3,064,000.00
- ARMP $4,699,000.00
- Revenue This Year
- BMR N/A
- ARMP $8.43
- Revenue Next Year
- BMR N/A
- ARMP N/A
- P/E Ratio
- BMR N/A
- ARMP N/A
- Revenue Growth
- BMR 5.33
- ARMP 14.24
- 52 Week Low
- BMR $1.86
- ARMP $0.90
- 52 Week High
- BMR $6.71
- ARMP $3.42
- Technical
- Relative Strength Index (RSI)
- BMR 59.44
- ARMP 58.73
- Support Level
- BMR $2.54
- ARMP $1.90
- Resistance Level
- BMR $3.00
- ARMP $2.20
- Average True Range (ATR)
- BMR 0.16
- ARMP 0.33
- MACD
- BMR 0.01
- ARMP 0.03
- Stochastic Oscillator
- BMR 82.61
- ARMP 55.46
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.